Fortress Biotech, Inc. Financial Ratios — FBIOP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-311.1	-85.79	-52.49	-21.47	-46.58	-38.08	-32.1	-43.49	-21.75	-16.62	-17.73	-25.06	-26.26	-29.51	4.13
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	100	31.13	78.79	77.22	71.25	67.99	53.36	59.37	72.91	63.8	66.92
EBITDA Margin (%)	- -	- -	- -	- -	-5,852.26	-391.89	-513.4	-438.72	-289.84	-195.06	-250.34	-256.41	-157.61	-185.13	-103.63
Operating Margin (%)	- -	- -	- -	- -	-5,855.27	-398.73	-520.71	-446.38	-302.54	-206.74	-260.21	-268.76	-164.71	-192.87	-111
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	-6,243.68	-432.58	-565.46	-486.57	-277.54	-225.55	-238.92	-281.83	-181.79	-209	-53.01
Profit Margin (%)	- -	- -	- -	- -	-5,611.59	-334.31	-387.8	-313.02	-109.09	-102.03	-94.06	-114.3	-71.75	-79.75	10.77
Net Income to Common Margin (%)	- -	- -	- -	- -	-5,611.59	-334.31	-387.8	-313.02	-109.09	-102.03	-94.06	-124.91	-81.25	-96.91	-2.97
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	13.88	- -	- -	- -	- -	- -	-0.23	-1.24	-1.57	-4.23	-3.31	-0.21	-0.29	2.52	9.88
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1	15	14	14	23	28	62	80	115	89	75	127	85	76	74
ST Debt	- -	2	6	- -	- -	2	13	19	9	6	7	13	6	3	2
LT Debt	1	13	7	14	23	26	49	60	106	83	68	115	79	73	72
Total Debt/EBITDA	-0.02	-0.54	-0.38	-0.7	-0.46	-0.44	-0.71	-0.67	-1.08	-1	-0.44	-0.66	-0.64	-0.71	-1.13
Net Debt/EBITDA	0.64	0.94	2.4	1.73	1.49	0.93	0.37	-0.12	0.44	1.9	1.47	0.39	0.13	-0.01	0.3
Total Debt/EBIT	-0.02	-0.54	-0.38	-0.7	-0.46	-0.43	-0.7	-0.66	-1.04	-0.94	-0.42	-0.63	-0.61	-0.68	-1.06
Net Debt/EBIT	0.64	0.94	2.4	1.73	1.48	0.91	0.36	-0.12	0.43	1.79	1.42	0.37	0.12	-0.01	0.28
EBITDA to Interest Expense	-473.27	-40.56	-18.6	-15.42	-34.03	-17.5	-11.52	-11.41	-12.45	-9.17	-15.11	-18.64	-11.18	-9.21	-7.53
EBITDA-CapEx/Interest Expense	-525.2	-40.97	-18.7	-15.42	-42.11	-20.35	-12.04	-12.31	-13.55	-9.9	-16.55	-18.94	-11.86	-10.51	-7.53
EBIT to Interest Expense	-473.57	-40.56	-18.61	-15.43	-34.05	-17.81	-11.68	-11.61	-12.99	-9.71	-15.71	-19.54	-11.68	-9.6	-8.06
Interest Expense	- -	1	2	1	1	4	8	10	9	10	11	10	12	12	9
Common Equity/Total Assets	-241.95	-205.31	-120.6	-158.61	-160.28	-143.62	-126.68	-280.55	-192.41	-144.76	-138.05	-215.5	-414.77	-513.68	-395.6
Long-Term Debt/Equity (%)	3.92	58.02	9.12	20.24	27.5	31.56	40.89	306.06	146.33	41.98	29.91	229.31	4,986.64	- -	116.07
Long-Term Debt/Capital (%)	-1.34	-18.37	-6.89	-11.22	-16.63	-15.18	-27.2	-20.27	-38.71	-27.85	-19.02	-23.01	-12.54	-10.55	-11.15
Long-Term Debt/Total Assets (%)	3.21	31.19	7.37	15.98	19.54	15.34	20.03	42.86	46.88	24.81	17.04	38.98	47.24	50.42	38.9
Total Debt/Equity (%)	3.92	66.19	16.75	20.47	27.67	34.01	51.87	402.69	158.75	45.22	33.19	254.56	5,334.66	-4,620.44	119.49
Total Debt/Capital (%)	-1.34	-20.96	-12.65	-11.34	-16.73	-16.36	-34.5	-26.66	-41.99	-30	-21.11	-25.54	-13.41	-11.02	-11.48
Total Debt/Total Assets (%)	3.21	35.58	13.54	16.16	19.66	16.53	25.41	56.39	50.85	26.72	18.91	43.27	50.54	52.67	40.04
Net Debt to Equity	-117.13	-116.26	-105.69	-50.7	-89.01	-72.41	-26.93	70.89	-65.09	-85.79	-112.39	-149.81	-1,075.68	-80.54	-31.97
Net Debt/Capital (%)	28.38	23.33	41.46	20.2	31.58	23.04	11.75	-3.85	11.49	31.87	38.41	11.07	2.4	-0.18	2.74
EBITDA	-35	-27	-36	-21	-51	-65	-89	-118	-106	-89	-172	-194	-133	-107	-66
EBITDA-CapEx	-39	-27	-36	-21	-62	-75	-93	-127	-116	-96	-189	-197	-141	-122	-66
Operating Income (Loss)	-35	-27	-36	-21	-51	-66	-90	-120	-111	-94	-179	-204	-139	-111	-70

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	6.63	7.83	8.88	17.11	9.28	1.62	1.83	1.49	3	4.51	3.03	1.4	0.95	0.8	1.6
Current Ratio	6.69	7.91	8.92	17.28	9.45	1.94	2.56	2	3.43	5.14	3.43	1.8	1.38	1.27	2.49
Quick Ratio	6.63	7.83	8.88	17.11	9.3	1.77	1.95	1.63	3.32	4.98	3.26	1.62	1.13	0.95	2.2
CFO/Avg Current Liab	-6.27	-5.38	-3.63	-2.14	-2.78	-1.36	-1.27	-1.56	-1.88	-1.72	-1.53	-1.57	-1.21	-1.03	-1.09
Common Equity/Total Assets	-241.95	-205.31	-120.6	-158.61	-160.28	-143.62	-126.68	-280.55	-192.41	-144.76	-138.05	-215.5	-414.77	-513.68	-395.6
Long-Term Debt/Equity (%)	3.92	58.02	9.12	20.24	27.5	31.56	40.89	306.06	146.33	41.98	29.91	229.31	4,986.64	- -	116.07
Long-Term Debt/Capital (%)	-1.34	-18.37	-6.89	-11.22	-16.63	-15.18	-27.2	-20.27	-38.71	-27.85	-19.02	-23.01	-12.54	-10.55	-11.15
Long-Term Debt/Total Assets (%)	3.21	31.19	7.37	15.98	19.54	15.34	20.03	42.86	46.88	24.81	17.04	38.98	47.24	50.42	38.9
Total Debt/Equity (%)	3.92	66.19	16.75	20.47	27.67	34.01	51.87	402.69	158.75	45.22	33.19	254.56	5,334.66	-4,620.44	119.49
Total Debt/Capital (%)	-1.34	-20.96	-12.65	-11.34	-16.73	-16.36	-34.5	-26.66	-41.99	-30	-21.11	-25.54	-13.41	-11.02	-11.48
Total Debt/Total Assets (%)	3.21	35.58	13.54	16.16	19.66	16.53	25.41	56.39	50.85	26.72	18.91	43.27	50.54	52.67	40.04
CFO/Total Liabilities	-258.12	-122.34	-153.57	-86.87	-59.35	-52.2	-64.81	-81.52	-61.71	-61.34	-68.3	-73.44	-77.27	-54.98	-53.32
CFO/CapEx	-2.85	-83.13	-157.69	- -	-1.7	-4.36	-20.26	-10.57	-10.11	-11.68	-7.13	-58.72	-15.83	-5.35	- -
Altman's Z-Score	-7.32	-4.02	-1.8	-2.09	-2.77	-3.56	-2.37	-6.14	-3.68	-2.15	-2.59	-5.09	-8.89	-11.78	-7.01

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	18.01	3.6	4.06	3.85	2.43	2.92	2.95	3.89	4.53	3.16
Days Sales Outstanding	- -	- -	- -	- -	- -	20.27	101.47	89.99	94.85	149.95	124.8	123.65	93.78	80.54	115.43
Inventory Turnover	- -	- -	- -	- -	- -	111.81	19.56	14.43	13.72	12.91	5.7	2.56	1.88	1.69	1.74
Days Inventory Outstanding	- -	- -	- -	- -	- -	3.26	18.66	25.3	26.6	28.27	64.08	142.45	194.23	215.35	209.81
Accounts Payable Turnover	- -	- -	- -	- -	- -	0.67	0.14	0.21	0.31	0.65	1.38	0.67	0.41	0.76	0.7
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	548.72	2,613.64	1,701.99	1,187.03	564.86	264.87	544.67	887	483.05	519.45
Cash Conversion Cycle	- -	- -	- -	- -	- -	-525.19	-2,493.51	-1,586.7	-1,065.58	-386.63	-75.99	-278.57	-598.99	-187.16	-194.21
Inventory to Cash Days	- -	- -	- -	- -	- -	17	82.81	64.7	68.25	121.68	60.71	-18.79	-100.45	-134.81	-94.38
Inventories	- -	- -	- -	- -	- -	- -	- -	1	1	1	10	14	10	14	10
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	6	5	3	3
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	4	8	5	11	7
Other Inventory	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	23	40	100	50	98	88	95	66	137	233	306	178	81	57	79
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	27	44	68	18	46	97	117	8	-21	-24	12
+ Total Debt	1	15	14	14	23	28	62	80	115	89	75	127	85	76	74
Enterprise Value	-22	-26	-86	-55	-47	-19	-1	14	25	-48	-114	-43	-17	-6	7
Total Capital	-56	-70	-108	-127	-139	-173	-181	-298	-274	-297	-355	-499	-631	-689	-647
Total Debt/Capital (%)	-1.34	-20.96	-12.65	-11.34	-16.73	-16.36	-34.5	-26.66	-41.99	-30	-21.11	-25.54	-13.41	-11.02	-11.48
Total Debt / EV	-0.03	-0.57	-0.16	-0.26	-0.49	-1.49	-119.05	5.57	4.68	-1.87	-0.66	-2.99	-4.92	-13.37	10.27
EV/Sales	- -	- -	- -	- -	- -	- -	- -	0.53	0.67	- -	- -	- -	- -	- -	0.11
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	-22	-26	-86	-35	-47	-16	35	32	25	-48	-114	-43	-17	-6	7
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	1	16	17	27	37	46	69	76	85	58	63
TTM EBITDA	-35	-27	-36	-21	-51	-65	-89	-118	-106	-89	-172	-194	-133	-107	-66
TTM Operating Income	-35	-27	-36	-21	-51	-66	-90	-120	-111	-94	-179	-204	-139	-111	-70
TTM Cash Flow to Firm	-11	-23	-28	-15	-19	-42	-73	-89	-86	-74	-105	-169	-116	-69	-57
TTM Free Cash Flow to Firm	-7	-22	-28	-15	-7	-32	-69	-79	-77	-67	-89	-166	-108	-54	-57

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-22	-26	-86	-55	-47	-19	-1	14	25	-48	-114	-43	-17	-6	7
Low Price	- -	- -	- -	- -	- -	- -	20.01	11.9	14.13	12	19.31	16.86	6.4	4.86	4.72
EV/Sales	- -	- -	- -	- -	- -	- -	- -	0.53	0.67	- -	- -	- -	- -	- -	0.11
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	2.06	1.19	0.67	- -	- -	- -	- -	- -	0.11
EV/Sales High	- -	- -	- -	- -	- -	- -	2.06	1.19	0.67	- -	- -	- -	- -	- -	0.11
EV/Sales Low	- -	- -	- -	- -	- -	- -	2.06	1.19	0.67	- -	- -	- -	- -	- -	0.11
EV/EBITDA Average	0.64	0.94	2.4	1.71	0.94	0.24	-0.4	-0.27	-0.23	0.54	0.66	0.22	0.13	0.05	-0.11
EV/EBITDA High	0.64	0.94	2.4	1.71	0.94	0.24	-0.4	-0.27	-0.23	0.54	0.66	0.22	0.13	0.05	-0.11
EV/EBITDA Low	0.64	0.94	2.4	1.71	0.94	0.24	-0.4	-0.27	-0.23	0.54	0.66	0.22	0.13	0.05	-0.11
EV/EBIT Average	0.64	0.94	2.4	1.71	0.94	0.24	-0.4	-0.27	-0.22	0.51	0.63	0.21	0.12	0.05	-0.1
EV/EBIT High	0.64	0.94	2.4	1.71	0.94	0.24	-0.4	-0.27	-0.22	0.51	0.63	0.21	0.12	0.05	-0.1
EV/EBIT Low	0.64	0.94	2.4	1.71	0.94	0.24	-0.4	-0.27	-0.22	0.51	0.63	0.21	0.12	0.05	-0.1
Last Price	- -	- -	- -	- -	- -	- -	22.75	14.39	20.48	19.39	25.88	17.65	11.87	6.65	9.49
High Price	- -	- -	- -	- -	- -	- -	24.8	23.96	21.95	21.54	26.69	26.41	20.35	18	9.85
Enterprise Value Average	-22	-26	-86	-35	-47	-16	35	32	25	-48	-114	-43	-17	-6	7
Enterprise Value High	-22	-26	-86	-35	-47	-16	35	32	25	-48	-114	-43	-17	-6	7
Enterprise Value Low	-22	-26	-86	-35	-47	-16	35	32	25	-48	-114	-43	-17	-6	7

Shares Outstanding	1	2	3	3	3	3	3	4	5	6	7	7	15	28	31
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash & Equivalents per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Tangible Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Fortress Biotech, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)